P33. NK-92 cellular immunotherapy as an alternative to donor derived peripheral blood NK cells

por Klingemann, H
Publicado 2014

Advances in clinical NK cell studies: Donor selection, manufacturing and quality control

por Koehl, U., Kalberer, C., Spanholtz, J., Lee, D. A., Miller, J. S., Cooley, S., Lowdell, M., Uharek, L., Klingemann, H., Curti, A., Leung, W., Alici, E.
Publicado 2015

High-dose chemotherapy and autologous bone marrow transplantation for patients with poor prognosis nonseminomatous germ cell tumours.

por Barnett, M. J., Coppin, C. M., Murray, N., Nevill, T. J., Reece, D. E., Klingemann, H. G., Shepherd, J. D., Nantel, S. H., Sutherland, H. J., Phillips, G. L.
Publicado 1993